Indicator Explainer
Somatostatin
Somatostatin (116 aa, ~13 kDa) is encoded by the human SST gene. This protein plays a role in the downregulation of somatotropin release.
This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.
When it is tested
Source: National Cancer Institute, NCI Thesaurus 26.09d, C28418. NCI definition, reproduced without modification under CC BY 4.0. Source identity and definition checked automatically on 2026-10-20. No individual clinical interpretation or human reviewer is asserted.
Reading results
Reference intervals and interpretation depend on the laboratory, specimen, method and clinical context. This source definition is educational information; it does not establish a diagnosis, product approval or suitability for an individual.
Also Known As
References
- NCI Thesaurus 26.09d — Somatostatin (C28418)
- Source: National Cancer Institute, NCI Thesaurus 26.09d, C28418. NCI definition, reproduced without modification under CC BY 4.0.
- The Use and Utility of Preoperative Somatostatin Receptor-Based Imaging in Gastroenteropancreatic Neuroendocrine Tumors. — Ann Surg Oncol, 2026-10-16 (PMID 42886322; literature)
- [177Lu]Lu-DOTATATE Versus High-Dose Somatostatin Analogues in Advanced Gastroenteropancreatic Neuroendocrine Tumors: Pooled Evidence From 3 Phase 3 Randomized Trials. — Am J Ther, 2026-10-16 (PMID 42881497; literature)
- Expression and Clinical Significance of Somatostatin Receptor 2 in Medullary Thyroid Carcinoma. — Neuroendocrinology, 2026-10-23 (PMID 42912727; literature)
- Normal variants, pitfalls, and interpretation challenges of somatostatin receptor PET. — Semin Nucl Med, 2026-10-24 (PMID 42926166; literature)